Dr. Nadine Rouphael (MD) is the Sumner E. Thompson, III Distinguished Professor of Vaccinology and Infectious Diseases at Emory University in Atlanta, USA. She serves as the executive director of the Hope Clinic, the clinical arm of the Emory Vaccine Center and the Emory principal investigator for the NIH funded Vaccine Treatment and Evaluation Unit (VTEU) and the co Clinical Core principal investigator for NIH funded Stanford Human Immunology Project Consortium (HIPC). She has served as the national chair/co-chair as well as overall PI/site PI of 75 clinical studies and an investigator on more than 200 studies. She has interest in antimicrobial resistance, vaccine clinical trials (pandemic influenza, Zika, Ebola, SARS-CoV2…), vaccine delivery methods (NIH funded phase 1 trial on microneedle influenza vaccine patch where a first in human dissolvable patch was shown to be safe, immunogenic and preferred to the traditional needle and syringe), translational research on innate immunity and systems biology (using vaccines as way to probe the immune system and one of the first to show an association between antibiotic use and decrease immunogenicity of vaccines), immune aging and correlates of protection. She has published more than 200 peer reviewed publications including manuscripts in NEJM, Lancet, Nature Immunology, Nature Medicine, Cell as first author and has received many awards including the Oswald Avery Award for IDSA. She is currently the associate editor for Clinical Infectious Diseases for the Vaccine section. She is passionate about mentoring the next generation of physician scientists and serves as Co-Director of the Stimulating Access to Research in Residency (StARR) R38 Program and the Director of the T32 vaccinology grant.